FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology, and can be used as a sedative and muscle relaxant drug containing hydroxyzine or its pharmaceutically acceptable salt - 0.00001–2.00002 wt. %, menthol solution in menthyl isovalerate- 0.99001–2.01106 wt. %, peppermint oil - 0.09807–0.14215 wt. %, Spanish hop oil - 0.017–0.020 wt. % and ethanol and purified water in weight ratio of 1.2:1–1.7:1 is the rest, made in the form of drops for oral administration, for therapy of functional disorders of cardiovascular system, tachycardia, neuroses and neurosis-like conditions accompanied by high excitability and irritability, anxiety, fear, difficulty falling asleep and sleep, as well as excitation conditions accompanied by manifested vegetative reactions and intestinal spasms.
EFFECT: therapeutic agent provides combination (synergetic) sedative and muscle relaxant action with reduced amount of active substances and fast provision of therapeutic effect.
3 cl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
SEDATIVE DRUG AND METHOD OF MARJORAM ESSENTIAL OIL PREPARING FOR MEDICINAL AIMS | 2000 |
|
RU2157224C1 |
SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
SEDATIVE AND SPASMOLITHIC MEANS AND METHOD FOR ITS PRODUCTION | 2015 |
|
RU2633064C2 |
SOLID DOSAGE FORM OF PREPARATION OF SEDATIVE AND HYPNOTIC EFFECT | 2013 |
|
RU2589833C2 |
MEDICINE OF SEDATIVE AND ANTISPASMODIC EFFECT AND METHOD OF PREPARATION (VERSIONS) | 2005 |
|
RU2349334C2 |
SOLID DRUG FORM OF MEDICATION WITH SEDATIVE AND ANTISPASMODIC EFFECT | 2013 |
|
RU2570374C2 |
COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR EXPRESS RELAXATION | 2016 |
|
RU2682888C2 |
COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
LIQUID SEDATIVE | 2021 |
|
RU2779256C1 |
Authors
Dates
2020-04-17—Published
2019-05-14—Filed